PAX9 and esophageal squamous cell carcinoma: When we pyrosequenced human ESCC cells (KYSE70) treated with a demethylating agent (5-aza-2′-deoxycytidine), CpG sites in the promoter regions of two PAX9 transcriptional start sites became demethylated, and meanwhile, PAX9 expression was induced.